跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 24,103 条关于
“OSE-CYTOMASK”
全部
24,103
临床试验
22,554
药物
377
机构
58
资讯
1,114
去年
Novel Gene Expression Signature Predicts Immunotherapy Response Across Cancer Types
去年
OSE Immunotherapeutics Announces Positive H1 2024 Results and Corporate Updates
去年
OSE Immunotherapeutics Advances Global Phase 3 Trial for Cancer Vaccine Tedopi
去年
OSE Immunotherapeutics Reports Strong Financial Results and Pipeline Progress in 2024
去年
OSE Immunotherapeutics and AbbVie Partner on Novel Anti-Inflammatory Program in $713M Deal
去年
Lusvertikimab Shows Promise in Ulcerative Colitis Phase 2 Trial
9个月前
OSE Immunotherapeutics Regains Control of ABBV-230 Early Development in Strategic Partnership Amendment with AbbVie
9个月前
OSE Immunotherapeutics Expands Lusvertikimab Program with New Autoimmune Indications in 2026-2028 Strategic Plan
去年
OSE Immunotherapeutics Leads €1.3 Million Consortium to Advance mRNA Therapeutics Using Lipid Nanoparticle Technology
6个月前
OSE Immunotherapeutics Receives Second Positive IDMC Recommendation for Phase 3 ARTEMIA Trial of Tedopi® in NSCLC
第 1 页,共 112 页
上一页
下一页